SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 681.76 |
| Enterprise Value ($M) | 162.49 |
| Book Value ($M) | 534.36 |
| Book Value / Share | 9.93 |
| Price / Book | 1.28 |
| NCAV ($M) | 474.09 |
| NCAV / Share | 8.81 |
| Price / NCAV | 1.44 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.24 |
| Return on Assets (ROA) | -0.19 |
| Return on Equity (ROE) | -0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.52 |
| Current Ratio | 11.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 534.98 |
| Assets | 595.25 |
| Liabilities | 60.89 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 7.10 | -9.91 | |
| 13G/A | Scully William P | 7.50 | 15.24 | |
| 13G/A | Fennell Todd W. | 5.89 | 0.87 | |
| 13G | Wellington Management Group Llp | 7.77 | -27.94 | |
| 13G/A | State Street Corp | 3.10 | -39.28 | |
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Fmr Llc | 15.00 | 52.90 | |
| 13G/A | BlackRock, Inc. | 7.00 | 8.19 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 81,928 | 263,179 | 31.13 | |
| 114,275 | 522,454 | 21.87 | |
| 110,832 | 322,329 | 34.38 | |
| 109,301 | 404,715 | 27.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PMVP – PMV Pharmaceuticals, Inc. | PRAX – Praxis Precision Medicines, Inc. |
| PRLD – Prelude Therapeutics Incorporated | PTCT – PTC Therapeutics, Inc. |
| PYXS – Pyxis Oncology, Inc. |
Financial data and stock pages provided by
Fintel.io